Search Results 2921-2930 of 16440 for Chronic Lymphocytic Leukemia
Monoclonal antibodies, such as atezolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...
This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...
Participation eligibility · Age < 18 years. · HbA1C > 9 % at enrollment. · Prior diagnosis, or signs and symptoms, of heart failure. · Currently taking a loop ...
Phase 4 trials look at long-term safety and effectiveness, after a new ... Diagnosis of non-alcoholic steatohepatitis (NASH) with presence of Stage 3 ...
The utility of molecular genetic testing is apparent in many settings, such as prenatal and pre-implantation diagnosis, risk assessment for familial cancer and ...
... diagnosis and progression), comorbidity burden, and performance status at index date. The study design allows a cross-sectional perspective with collection ...
Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with breast conditions.
D., focuses mainly on sex hormone signaling, estrogen receptor biology, and new therapeutic targets in breast and ovarian cancers. The collaborative laboratory ...
Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of step 2 ...
Age ≥ 18 years. · Recurrent, persistent, or progressive epithelial ovarian, fallopian tube, or primary peritoneal cancer after treatment with bilateral ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.